Position in NAGE
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$946,760
-$350,680 QoQ
Shares Held
214,685
+5.2% QoQ
Ownership
0.270%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NAGE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GABELLI FUNDS LLC holds $96,689,277 across 29 Biotechnology names. NAGE ranks #14 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ACLX |
Arcellx, Inc.
|
195,900 | $22,493,238 | |
| 2 | TERN |
Terns Pharmaceuticals, Inc.
|
271,857 | $14,332,301 | |
| 3 | FOLD |
AMICUS THERAPEUTICS, INC.
|
942,650 | $13,630,719 | |
| 4 | APLS |
Apellis Pharmaceuticals, Inc.
|
321,200 | $12,921,876 | |
| 5 | DAWN |
Day One Biopharmaceuticals, Inc.
|
464,097 | $9,950,239 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
65,300 | $4,849,178 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,920 | $3,536,596 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
46,200 | $2,985,906 |
All Filings in NAGE
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $946,760 | 214,685 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,297,440 | 204,000 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $1,749,375 | 187,500 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,736,459 | 189,900 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,413,120 | 204,800 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,008,900 | 190,000 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $730,000 | 200,000 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $546,000 | 200,000 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $696,000 | 200,000 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $286,000 | 200,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $262,800 | 180,000 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $259,050 | 165,000 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $239,904 | 156,800 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $87,360 | 52,000 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $34,440 | 28,000 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||